Aignosis | Rs 4 Cr (Seed)

Founders: Raksheet Jain, Divyansh Mangal

Founded: 2025

HQ: Jaipur

Sector: HealthTech / AI Diagnostics

What they do

→ Built an AI-assisted screening platform for autism and developmental concerns in children aged 16 months to 9 years

→ Uses a standard laptop and webcam to record short videos across nine stimulus-based modules

→ Computer vision analyses gaze patterns, response to name and reactions to facial expressions

→ Generates a risk report flagging whether a child needs further clinical evaluation, not a diagnosis

The Funding

→ Raised Rs 4 crore in seed funding

→ Led by Antler, Nikhil Kamath and angels including Varun Dua and IIMA Ventures

→ Follows a first round in 2024 from investors including Rajneesh Bhandari and @Amit Jain

→ Capital earmarked for strengthening the platform and expanding reach across India

Why it matters

→ Has completed CDSCO regulatory process and received Class B certification

→ Selected for Google for Startups Accelerator: AI First 2025 cohort

→ Deployed across 20+ government Primary Health Centres in Rajasthan, with Mankind Pharma for screening camps and Apollo Shines for school screenings

→ Has run 8,000+ screenings, targeting 1 lakh by end of FY27, and plans to expand into Punjab, NCR, Haryana, Tamil Nadu, Jharkhand, Karnataka and Maharashtra

Can AI-based screening meaningfully close India's autism diagnosis gap, or does the hard part start after the flag is raised